{"id":"NCT00498173","sponsor":"Massachusetts General Hospital","briefTitle":"Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism","officialTitle":"Targeted Pharmacologic Interventions for Autism: A Double-Blind, Placebo-Controlled Trial of Atomoxetine in Children and Adolescents With Autism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2015-10","completion":"2015-10","firstPosted":"2007-07-09","resultsPosted":"2017-08-14","lastUpdate":"2017-08-14"},"enrollment":60,"design":{"allocation":"RANDOMIZED","model":"SEQUENTIAL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Autism"],"interventions":[{"type":"DRUG","name":"Atomoxetine","otherNames":["Strattera"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Atomoxetine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the effectiveness of atomoxetine in treating children with attention deficit hyperactivity disorder symptoms associated with autistic disorder, Asperger's syndrome, and pervasive developmental disorder, not otherwise specified.","primaryOutcome":{"measure":"ADHD Rating Scale (ADHDRS)-Home Version Total Score (Randomized Phase)","timeFrame":"8 weeks","effectByArm":[{"arm":"Atomoxetine","deltaMin":28.7,"sd":null},{"arm":"Placebo","deltaMin":34,"sd":null}],"pValues":[]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["37811711"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":["Appetite decrease","Irritability","Sedation/drowsiness","Aggression","Headache"]}}